Featured

  • April 15, 2025
  • North America
  • Healthcare

Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States

NEW YORK, NY – April 15, 2025 – Click Therapeutics, Inc., (“Click”) a leader in prescription medical treatments as both prescription digital therapeutics and software-enhanced drug™ therapies, has obtained FDA marketing authorization for the first prescription digital therapeutic for the preventive…

Read More

  • March 19, 2025
  • Europe
  • Healthcare

Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience with Investment in Click Therapeutics for Digital Therapeutics beyond Clinical Trials

Velizy-Villacoublay, France – March 19, 2025 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics and software-enhanced drug therapies. The transaction advances Dassault Systèmes’ transformation of the patient experience in…

Read More

All Releases

Reset Filters

  • February 19, 2025
  • North America
  • Healthcare

On Target Laboratories Awarded “Most Innovative Product of the Year” by Best in Biz – On Target

West Lafayette, IN – February 19, 2025 – On Target Laboratories is pleased to share it has been named a Gold Winner in the 2024 Best in Biz awards. The company’s product, CYTALUX® (pafolacianine) injection, was recognized in the “Most Innovative Product of …

Read More

  • September 23, 2024
  • North America
  • Healthcare

H.I.G. Capital Completes the Sale of BIOVECTRA

MIAMI – September 23, 2024 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $65 billion of capital under management, is pleased to announce the sale of its portfolio company, BIOVECTRA Inc. (“BIOVECTRA” or the “Company”), a leading …

Read More

  • April 1, 2024
  • North America
  • Healthcare

H.I.G. Capital Acquires the Spine Business of ZimVie Rebranded as Highridge Medical

MIAMI – April 1, 2024 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce that one of its affiliates has completed the acquisition of the Spine division of …

Read More

  • January 3, 2024
  • North America
  • Healthcare

On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board

WEST LAFAYETTE, IN – January 3, 2024 – On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the appointment of Scott Huennekens as Executive Chairperson of the Board. A 30-year …

Read More

  • November 16, 2023
  • North America
  • Healthcare

On Target Laboratories Secures $30 Million for Commercialization of CYTALUX® (pafolacianine) injection

WEST LAFAYETTE, IN – November 16, 2023 – On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery, today announced the completion of a $30 million Series C financing. This significant investment …

Read More

  • September 19, 2023
  • North America
  • Healthcare

Rising Pharmaceuticals Bolsters U.S. Supply Chain by Expanding Sterile Dosage Capabilities, Including Injectables and Ophthalmics, with Opening of New Facility

EAST BRUNSWICK, N.J. – September 19, 2023 – Rising Pharma Holdings Inc., dba as Rising Pharmaceuticals, today announced the opening of a commercial manufacturing facility in Decatur, Illinois, to manufacture and package sterile products, including injectables and ophthalmic products in …

Read More

  • September 7, 2023
  • North America
  • Healthcare

Click Therapeutics Announces Collaboration with Indivior to Develop and Commercialize Novel Prescription Digital Therapeutics in Substance Use Disorders

NEW YORK – September 7, 2023 – Click Therapeutics today announced the execution of a new collaboration agreement with Indivior for the development and commercialization of prescription digital therapeutics to treat substance use disorders, beginning with Opioid Use Disorder (OUD). Through a …

Read More

  • August 23, 2023
  • North America
  • Healthcare

Leiters Health Ranks No. 2069 on the 2023 Inc. 5000

NEW YORK – August 23, 2023 – Inc. revealed today that Leiters Health ranks No. 2069 on the 2023 Inc. 5000, its annual list of the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful …

Read More

  • July 31, 2023

Augmedics strengthens AR/AI portfolio with planned acquisition of Surgalign digital health assets

CHICAGO – July 31, 2023 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has been named the successful bidder for the digital health assets of Surgalign and Holo Surgical following a competitive auction process. The …

Read More

  • July 3, 2023

Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution

BRIDGEWATER, NJ – July 3, 2023 – Nevakar Injectables Inc. (“Nevakar”), a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, announced today that the U.S. Food and Drug Administration (“FDA”) has approved …

Read More

Displaying 10 of 198 News Articles

×